EM
SLS icon

ELCO Management’s SELLAS Life Sciences SLS Stock Holding History

ELCO Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$210K Sell
14,209
-400
-3% -$2.76K 0.09% 167
2026
Q1 		$61.8K Hold
14,609
– – 0.03% 168
2025
Q4 		$55.1K Buy
14,609
+600
+4% +$1.17K 0.03% 155
2025
Q3 		$22.6K Buy
+14,009
New +$25K 0.01% 164

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

ELCO Management's SLS Position: Q2 2026 in Review

ELCO Management reduced its SELLAS Life Sciences (SLS) stake by 2.7% in Q2 2026, selling an estimated $2.76K and leaving 14,209 shares worth $210K. The position accounts for 0.09% of the portfolio, ranked #167.

ELCO Management first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • ELCO Management held 14,209 shares of SELLAS Life Sciences worth $210K as of Q2 2026.
  • ELCO Management sold 400 SELLAS Life Sciences shares in Q2 2026, an estimated $2.76K.
  • SELLAS Life Sciences made up 0.09% of ELCO Management's portfolio in Q2 2026, its #167 holding.
  • ELCO Management first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on ELCO Management's 13F filing for Q2 2026, filed 11 Aug 2026.